Lisata Therapeutics Inc.

2.22
0.07 (3.26%)
At close: Mar 04, 2025, 11:54 AM

Lisata Therapeutics Income Statement

Year FY24 FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14 FY13 FY12 FY11 FY10 FY09 FY08 FY07 FY06 FY05 FY04 FY03 FY02 FY01 FY00 FY99 FY98 FY97 FY96 FY95 FY94 FY93 FY90
Revenue 1M n/a 121.37M n/a n/a n/a n/a n/a 35.28M 22.49M 17.94M 14.67M 14.33M 10.05M 69.82M 11.57M 83.54K 231.66K 45.72K 35.26K 48.56K 64.63K 81.35K 107.45K 531.76K 12.85K n/a n/a n/a 21.05M 7.59M 340K 4.5M
Cost of Revenue n/a 189K 57.6M 55K 63K 65K 225K 372K 31.14M 20.16M 15.68M 12.95M 11.95M 8.65M 49.67M 7.59M 31.98K 24.85K 22.4K 24.78K 33.88K 43.61K 60.56K 70.67K 111.17K -74.78K n/a n/a n/a 15.53M n/a n/a 1.42M
Gross Profit 1M -189K 63.77M -55K -63K -65K -225K -372K 4.15M 2.33M 2.26M 1.72M 2.38M 1.4M 20.15M 3.98M 51.56K 206.82K 23.33K 10.49K 14.68K 21.02K 20.78K 36.77K 420.59K 87.64K n/a n/a n/a 5.52M 7.59M 340K 3.08M
Operating Income -22.41M -25.71M -57.6M -29.05M -19.14M -20.09M -16.99M -27.59M -31.34M -113.85M -57.74M -36.81M -30.39M -34M -18.88M -23.8M -9.23M -10.44M -4.69M -1.6M -1.47M -894.33K -1.15M -1.61M -2.3M -1.06M n/a -251.58K -257.07K -3.92M 210K 20K -1.49M
Interest Income n/a 2.72M n/a 151K 132K 740K n/a n/a n/a n/a n/a n/a n/a n/a n/a 52.07K 3.04K 15.33K 20.43K 137.00 n/a 88.92K n/a n/a 169.27K n/a n/a n/a n/a n/a n/a n/a n/a
Pretax Income -20.78M -23.17M -56.7M -28.97M -19.01M -19.35M -16.17M -27.7M -33.17M -98.25M -55.57M -38.71M -36.28M -56.19M -18.85M -23.84M n/a n/a n/a n/a -2.2M -1.12M -1.47M -1.89M -2.19M n/a n/a -268.96K -260.71K -3.38M n/a 20K -1.96M
Net Income -19.98M -20.84M -54.23M -27.47M -8.14M -20.1M -16.17M 22.98M -32.66M -80.89M -54.87M -38.98M -53.77M -47.13M -23.31M -25.27M -9.24M -10.45M -6.05M -1.75M -1.75M -1.04M -1.16M -2.03M -2.03M -1.11M n/a -332.6K 1.71M -3.37M n/a n/a -2.71M
Selling & General & Admin 12.07M 12.97M 14.14M 11.37M 9.89M 9.29M 9.39M 11.75M 20.37M 30.01M 30.81M 21.61M 22.32M 27.69M 31.35M 23.46M 9.29M 10.65M 4.71M 1.61M 763.64K 685.35K 911.95K 1.64M 2.56M 1.06M n/a 251.58K 257.07K 8.34M 7.38M 320K 3.24M
Research & Development 11.33M 12.73M 43.46M 17.68M 9.25M 10.8M 7.59M 15.84M 15.11M 23.9M 29.19M 16.92M 10.45M 7.72M 7.68M 4.32M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 1.33M
Other Expenses n/a n/a -155K -75K 132K 740K 824K 273.1K 21.96K 17.72M 2.93M -1.61M -4.31M n/a n/a n/a n/a n/a n/a n/a 725.32K 230K 258.1K n/a 155.64K 82.34K n/a n/a n/a n/a n/a n/a n/a
Operating Expenses 23.41M 25.71M 57.6M 29.05M 19.14M 20.09M 16.99M 27.59M 35.48M 53.9M 60M 38.53M 32.77M 35.41M 39.03M 27.78M 9.29M 10.65M 4.71M 1.61M 1.49M 915.35K 1.17M 1.64M 2.72M 1.14M n/a 251.58K 257.07K 8.34M 7.38M 320K 4.57M
Interest Expense n/a n/a n/a n/a n/a n/a 5K 377.77K 1.86M 2.13M 755.7K 281.42K 1.58M 2.65M 480.9K 91.26K 11.66K 21.97K 1.38M 144.26K n/a 238.74K n/a n/a 10.14K n/a n/a n/a n/a -540K -160K n/a -280K
Selling & Marketing Expenses n/a n/a n/a n/a n/a n/a n/a n/a 20.36M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses 23.41M 25.71M 57.6M 29.05M 19.14M 20.09M 16.99M 27.59M 66.62M 74.06M 75.68M 51.48M 44.72M 44.05M 88.7M 35.37M 9.32M 10.67M 4.74M 1.64M 1.52M 958.96K 1.23M 1.71M 2.83M 1.07M n/a 251.58K 257.07K 23.87M 7.38M 320K 5.99M
Income Tax -798K -2.33M -2.48M -1.51M -10.87M 749K -1K -11.53M 138.04K -17.24M -104.2K 780.1K -175.53K 392.77K 550.91K 344.2K -3.04K 6.64K -20.43K -137 999.41K 141.08K 326.89K 713.48K -390.93K 56.97K n/a 81.02K -1.97M -10K n/a 20K 750K
Shares Outstanding (Basic) 8.33M 8.07M 5.18M 3.69M 1.03M 688.33K 645.93K 597.93K 436.55K 323.39K 218.37K 136.64K 92.28K 59.06K 34.42K 8.68K 4.04K 2.19K 1.39K 470.00 273.00 175.00 149.00 148.00 148.00 83.00 635.00 16.00 16.00 241.00 241.00 241.00 241.00
Shares Outstanding (Diluted) 8.33M 8.07M 5.18M 3.69M 1.03M 688.33K 645.93K 597.93K 436.55K 323.39K 218.37K 136.64K 92.28K 59.06K 34.42K 8.68K 4.04K 2.19K 1.39K 470.00 273.00 175.00 149.00 148.00 148.00 83.00 635.00 16.00 16.00 241.00 241.00 241.00 241.00
EPS (Basic) -2.4 -2.58 -10.47 -7.45 -7.91 -29.2 -25.03 38.43 -74.81 -250.12 -251.28 -285.29 -582.68 -798.01 -677.08 -2.91K -2.29K -4.77K -4.37K -3.71K -6.4K -5.97K -7.78K -13.74K -13.7K -13.4K n/a -20.79K 106.94K -13.98K n/a n/a -11.24K
EPS (Diluted) -2.4 -2.58 -10.47 -7.45 -7.91 -29.2 -25.03 38.43 -74.81 -250.12 -251.28 -285.29 -582.68 -798.01 -677.08 -2.91K -2.29K -4.77K -4.37K -3.71K -6.4K -5.97K -7.78K -13.74K -13.7K -13.4K n/a -20.79K 106.94K -13.98K n/a n/a -11.24K
EBITDA n/a -25.52M -115.2M -29M -19.08M -20.03M -16.76M -27.22M -29.03M -93.44M -52.63M -36.82M -33.15M -30.48M -13.23M -23.22M -9.11M -10.39M -4.45M -1.59M -1.47M -893.68K -1.13M -1.45M -2.36M -941.49K n/a -251.19K -255.32K -3.46M 310K 30K -2.24M
Depreciation & Amortization n/a 189K 69K 55K 63K 65K 225K 372K 450.27K 2.69M 2.19M 1.61M 1.55M 1.44M 5.14M 577.04K 115.96K 53.78K 240.12K 7.84K 13.54K 646.00 16.77K 155.44K 155.64K 82.34K n/a 388.00 1.75K 460K 100K 10K -750K